review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0013-7006(06)76133-4 |
P698 | PubMed publication ID | 16633287 |
P2093 | author name string | S Friedman | |
J Thuile | |||
J D Guelfi | |||
R Dardennes | |||
P2860 | cites work | Suicide as an outcome for mental disorders. A meta-analysis | Q28244203 |
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey | Q28258215 | ||
The use of administrative data to assess quality of care for bipolar disorder in a large staff model HMO. | Q30587195 | ||
Does lithium treatment still work? Evidence of stable responses over three decades | Q33832738 | ||
Use of services by persons with mental and addictive disorders. Findings from the National Institute of Mental Health Epidemiologic Catchment Area Program | Q34355216 | ||
Prescribing of psychotropic medication by primary care physicians and psychiatrists | Q34560744 | ||
Costs of bipolar disorder | Q35154704 | ||
Insurance expenditures on bipolar disorder: clinical and parity implications | Q35165454 | ||
Lithium treatment: prescribing and monitoring habits in hospital and general practice | Q35820274 | ||
Affective disorders in a US urban community: the use of research diagnostic criteria in an epidemiological survey | Q39213969 | ||
The epidemiology of bipolar affective disorder | Q40944729 | ||
Lithium use and discontinuation in a health maintenance organization | Q41014056 | ||
Costs of schizophrenia | Q41728231 | ||
Epidemiology of mood disorders: a community survey in Florence | Q43438369 | ||
Illness characteristics and their association with prescription patterns for bipolar I disorder | Q43546337 | ||
Trends in the treatment of bipolar disorder by outpatient psychiatrists | Q44013090 | ||
Manic episodes: the direct cost of a three-month period following hospitalisation | Q44180646 | ||
Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes. | Q44418395 | ||
Estimates of the prevalence of bipolar affective disorder. Methods based on treatment with lithium | Q44470249 | ||
The treated prevalence of bipolar disorder in a large staff-model HMO. | Q45017537 | ||
Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic | Q45220527 | ||
Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis. | Q45291868 | ||
Predictors of service utilization in veterans with bipolar disorder: a prospective study | Q45335276 | ||
Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program | Q46319819 | ||
Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). | Q47440847 | ||
Cross-national epidemiology of major depression and bipolar disorder | Q47826731 | ||
The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey. | Q48777454 | ||
The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services | Q50127660 | ||
The enduring psychosocial consequences of mania and depression. | Q50608957 | ||
The incidence and onset-age of hospitalized bipolar affective disorder in Finland. | Q50629043 | ||
Annual cost of bipolar disorder to UK society. | Q50692260 | ||
Rapid cycling in women and men with bipolar manic-depressive disorders. | Q50863185 | ||
Clinical subtypes of bipolar mixed states: validating a broader European definition in 143 cases. | Q50951201 | ||
A prospective follow-up of patients with bipolar and primary unipolar affective disorder. | Q51053324 | ||
The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999. | Q51950919 | ||
Medical resource use among patients treated for bipolar disorder: a retrospective, cross-sectional, descriptive analysis. | Q51951926 | ||
Health care utilization and costs among patients treated for bipolar disorder in an insured population. | Q51981174 | ||
Lithium: a brake in the rising cost of mental illness. | Q52104831 | ||
The epidemiology of DSM-III-R bipolar I disorder in a general population survey. | Q53357821 | ||
Bipolar I: A Five-Year Prospective Follow-up | Q60447096 | ||
Differential Outcome of Pure Manic, Mixed/Cycling, and Pure Depressive Episodes in Patients With Bipolar Illness | Q60447147 | ||
The Stanley Foundation Bipolar Treatment Outcome Network | Q61480091 | ||
Extent and determinants of burden among families of patients with affective disorders | Q67566391 | ||
Four-year follow-up of twenty-four first-episode manic patients | Q68423068 | ||
The course of affective disorders | Q69002669 | ||
Lithium treatment in Aarhus. 1. Prevalence | Q69658540 | ||
The impact of lithium in South-west Scotland. II. A longitudinal study | Q70069966 | ||
The Family Attitudes Questionnaire. Patients' and spouses' views of bipolar illness | Q70785303 | ||
Course and outcome in bipolar affective disorder: a longitudinal follow-up study | Q72565096 | ||
The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members | Q72879442 | ||
Burden experienced by care-givers of persons with bipolar affective disorder | Q73326042 | ||
Bipolar disorder | Q73874573 | ||
Excess mortality of mental disorder | Q77670488 | ||
P433 | issue | 1 Pt 1 | |
P921 | main subject | bipolar disorder | Q131755 |
P1104 | number of pages | 8 | |
P304 | page(s) | 18-25 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | L'Encephale: revue de psychiatrie clinique biologique et therapeutique | Q3202945 |
P1476 | title | [The costs of bipolar disorder] | |
P478 | volume | 32 |
Q40146888 | Factors associated with treatment nonadherence among US bipolar disorder patients | cites work | P2860 |
Search more.